Currently Viewing:
AMCP 2017
Dr Jennifer Graff on How Payers Make Decisions
August 01, 2017
Laura Topor Discusses Challenges of e-Prescribing Specialty Medications
July 11, 2017
Dr Jacqueline Glover: Financial Knowledge Is Part of Informed Consent
July 10, 2017
Laura Topor Explains the Value of Real-Time Benefit Transactions
June 27, 2017
Dr Jacqueline Glover: Clinicians' Obligations of Justice Regarding Costs of Care
June 24, 2017
Dr Lou Garrison Discusses Challenges of Working With Real-World Data
June 16, 2017
Dr Neil Minkoff Explains How 340B Impacts Pharmacies and Payers Differently
June 15, 2017
Currently Reading
Dr Matthew Pickering on Working With Health Plans on Measure Implementation
June 09, 2017
Dr Jacqueline Glover Discusses the Complicated Balance of Ethics in Drug Trials
June 05, 2017
Dr Richard J. Willke Discusses Challenges of Working With Real-World Data
June 02, 2017
Susan A. Cantrell Explains the Necessity of Pre- and Post-Approval Communications
May 31, 2017
Dr Neil Minkoff Discusses Evolution and Consequences of 340B Programs
May 30, 2017
Dr Doug Hillblom Discusses Legislative Pushes Toward e-Prescribing
May 25, 2017
Dr Matthew Pickering Describes Challenges of New Measure Implementation
May 24, 2017
Dr Aimee Tharaldson Discusses the Orphan Drug Approval Trend
May 22, 2017
Dr Gail Bridges on the Importance of Real-World Results Matching Clinical Trial Outcomes
May 21, 2017
Dr Liz Zhou Discusses Real-World Implications of Toujeo Switching Trial
May 19, 2017
Dr Richard J. Willke on the Value of Real-World Data for Health Plans
May 18, 2017
Dr Lou Garrison on the Discussions Surrounding Outcomes-Based Arrangements
May 17, 2017

Dr Matthew Pickering on Working With Health Plans on Measure Implementation

A measure developer's work isn't done once a quality measure is created-the Pharmacy Quality Alliance (PQA) works with health plans post-implementation on questions regarding measure specifications or measure calculations, explained Matthew Pickering, PharmD, RPh, associate director of research and quality strategies at PQA.


A measure developer's work isn't done once a quality measure is created—the Pharmacy Quality Alliance (PQA) works with health plans post-implementation on questions regarding measure specifications or measure calculations, explained Matthew Pickering, PharmD, RPh, associate director of research and quality strategies at PQA.

Transcript

How does the Pharmacy Quality Alliance work with healht plans on implementation of new quality measures?

PQA engages with health plans post-implementation on its measures by answering any questions they may have about how to accurately calculate the measure. Or if there is measure specification questions about how to identify the most eligible population for the measure, the exclusions, etc. So we try to provide feedback for those questions with those health plans, especially with our member organizations who consist of health plans,

We also engage those health plans who are our members in our measure updates. So when we update our measures, we have representatives from those health plans sit in on those panels that provide feedback from what they've experienced in the field based on those measures. And that feedback is very valuable as we think about new specifications or new medications to consider for the update of that measure to when it's implemented again.

 
Copyright AJMC 2006-2017 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up
×

Sign In

Not a member? Sign up now!